I’ve been in the field of IVF for years, yet it was a failed cycle that truly opened my eyes to the complexities that textbooks often gloss over. A few months ago, I found myself sitting across from a couple whose IVF cycle had just failed. It was a moment filled with raw emotion — disappointment, confusion, and a palpable sense of loss filled the room. As a doctor, it’s easy to focus on the medical aspects, the numbers, and the protocols, but this experience reminded me that the human element is equally, if not more, important.
Medical textbooks can teach us about the mechanics of IVF — the hormonal protocols, the statistical success rates, and the technicalities of embryo transfer. However, what they often fail to capture is the emotional rollercoaster that patients endure. This is akin to the world of angel investing, where numbers and projections can only take you so far. It’s the passion and resilience of the founders that often make or break a venture. In both fields, the human element is crucial and cannot be quantified.
The failed IVF cycle in question was technically unremarkable. The couple was young, the stimulation protocol was textbook-perfect, and the embryos were graded as top quality. Yet, as any seasoned IVF specialist will tell you, doing everything “right” doesn’t guarantee a successful pregnancy. This is a hard pill to swallow for both patients and doctors. It’s a reminder that while we strive for control, biology often has the final say. Like in investing, where you might back a startup with all the right ingredients and still watch it falter, IVF outcomes can be just as unpredictably fickle.
The immediate aftermath of a failed cycle is a period of emotional and physical recovery. Patients often experience hormonal imbalances, akin to withdrawing from a powerful medication. This can manifest as mood swings, fatigue, and physical discomfort. Yet, the emotional toll is often more profound. The couple I mentioned earlier faced not just the disappointment of a negative test but also the societal pressures and personal guilt that often accompany fertility struggles. This is where empathy becomes our most valuable tool as practitioners. It’s not enough to adjust the protocol; we must also address the emotional scars.
Reflecting on this, I realized that in the realm of angel investing, I often find myself advising founders on resilience. Failure is not the end but a learning opportunity. The same applies to IVF. A failed cycle, while disheartening, provides valuable insights into what might be refined or approached differently in future attempts. It’s a test of patience and perseverance — qualities that founders and patients alike must cultivate.
One of the key lessons from this experience is the importance of communication. In my practice, I now emphasize debriefing sessions after a failed cycle. These sessions are not just about reviewing what went wrong but also about reaffirming the patient’s emotional well-being. I ask questions like, “How are you feeling about this?” and “What can we do to support you better?” These conversations often reveal insights that purely medical assessments might miss. It’s a page right out of my angel investing playbook, where knowing the founder’s mindset can be as critical as understanding their business model.
Another parallel between IVF and investing is the concept of risk. In both fields, the risk is inherent and must be managed rather than avoided. Patients undergoing IVF are well aware of the risks involved, from the physical side effects to the financial burden. Similarly, investors know that not every startup will succeed. The art lies in managing these risks and preparing for multiple outcomes. In IVF, this might mean exploring additional diagnostic tests or considering alternative treatment options. In investing, it might involve diversifying one’s portfolio or providing additional support to a struggling startup.
The emotional resilience required in both IVF and investing cannot be overstated. For patients, this means allowing themselves to grieve a failed cycle but also finding the strength to try again. For founders, it means learning from setbacks and remaining committed to their vision despite obstacles. In both cases, the journey is arduous but potentially rewarding.
This brings me to a final observation: the power of hope. Hope is a double-edged sword in both fields. It can drive you forward or leave you devastated when expectations aren’t met. Yet, it’s an essential ingredient. In IVF, hope keeps patients persevering through cycle after cycle. In investing, hope fuels the belief that a startup can change the world. Managing hope — keeping it alive while grounding it in reality — is one of the most challenging aspects of my dual roles as a doctor and an investor.
In conclusion, the day I learned more from a failed IVF cycle than any medical textbook was the day I truly understood the interplay between the emotional and the medical, the human and the procedural. Just as a startup founder learns from each failure, each IVF cycle — successful or not — teaches us something new. It’s a reminder that while science and numbers are crucial, empathy, resilience, and hope are equally indispensable. These are lessons I carry with me, whether I’m in the clinic with a patient or in a boardroom with a founder. They are not separate worlds, after all, but parallel journeys of hope, risk, and the relentless pursuit of success.